LIFECORE BIOMEDICAL, INC. Payments of Debt Issuance Costs
LIFECORE BIOMEDICAL, INC. (LFCR) reported Payments of Debt Issuance Costs of $435.00 thousand for the 12-month period ending 2025-05-25, per its 10-K filed 2025-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2025-08-07
- LIFECORE BIOMEDICAL, INC. payments of debt issuance costs for the quarter ending 2025-05-25 was $0.00, a 100.00% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. payments of debt issuance costs for the quarter ending 2024-05-26 was $107.00K, a 95.51% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. payments of debt issuance costs for the quarter ending 2023-05-28 was $2.38M, a 265.18% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. payments of debt issuance costs for the quarter ending 2023-02-26 was $3.67M, a 9816.22% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. payments of debt issuance costs for fiscal 2025 was $435.00K, a 88.31% increase from fiscal 2024.
- LIFECORE BIOMEDICAL, INC. payments of debt issuance costs for fiscal 2024 was $231.00K, a 96.18% decline from fiscal 2023.
- LIFECORE BIOMEDICAL, INC. payments of debt issuance costs for fiscal 2023 was $6.05M, a 636.91% increase from fiscal 2022.
- LIFECORE BIOMEDICAL, INC. payments of debt issuance costs for fiscal 2022 was $821.00K, a 92.17% decline from fiscal 2021.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2025-05-25 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-07 | $435.00K 10-K · filed 2025-08-07 | ||
| 2025-02-23 | $435.00K 10-Q · filed 2025-04-03 | |||
| 2024-05-26 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-07 | $231.00K 10-K · filed 2025-08-07 | ||
| 2024-02-25 | $124.00K 10-Q · filed 2025-04-03 | |||
| 2023-05-28 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26 | $6.05M derived: sum of 2 quarters · filed 2024-08-26 | $6.05M derived: sum of 3 quarters · filed 2024-08-26 | $6.05M 10-K · filed 2024-08-26 |
| 2023-02-26 | $3.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | $3.67M derived: sum of 2 quarters · filed 2024-08-09 | $3.67M 10-Q · filed 2024-08-09 | $4.32M derived: sum of 4 quarters · filed 2024-08-26 |
| 2022-11-27 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-03-16 | $0.00 10-Q · filed 2023-03-16 | $652.00K derived: sum of 3 quarters · filed 2024-08-26 | $689.00K derived: sum of 4 quarters · filed 2024-08-26 |
| 2022-08-28 | $0.00 10-Q/A · filed 2023-03-16 | $652.00K derived: sum of 2 quarters · filed 2024-08-26 | $689.00K derived: sum of 3 quarters · filed 2024-08-26 | $689.00K derived: sum of 4 quarters · filed 2024-08-26 |
| 2022-05-29 | $652.00K derived: 10-K 12 month − 10-K 9 month · filed 2024-08-26 | $689.00K derived: sum of 2 quarters · filed 2024-08-26 | $689.00K derived: sum of 3 quarters · filed 2024-08-26 | $821.00K 10-K · filed 2024-08-26 |
| 2022-02-27 | $37.00K derived: 10-K 9 month − 10-K 6 month · filed 2024-03-20 | $37.00K derived: sum of 2 quarters · filed 2024-03-20 | $169.00K 10-K · filed 2024-03-20 | $1.04M derived: sum of 4 quarters · filed 2024-03-20 |
| 2021-11-28 | $0.00 derived: 10-K 6 month − 10-K 3 month · filed 2024-03-20 | $132.00K 10-K · filed 2024-03-20 | $1.00M derived: sum of 3 quarters · filed 2024-03-20 | $9.38M derived: sum of 4 quarters · filed 2024-03-20 |
| 2021-08-29 | $132.00K 10-K · filed 2024-03-20 | $1.00M derived: sum of 2 quarters · filed 2024-03-20 | $9.38M derived: sum of 3 quarters · filed 2024-03-20 | $10.10M derived: sum of 4 quarters · filed 2024-03-20 |
| 2021-05-30 | $869.00K derived: 10-K 12 month − 10-K 9 month · filed 2024-03-20 | $9.25M derived: sum of 2 quarters · filed 2024-03-20 | $9.97M derived: sum of 3 quarters · filed 2024-03-20 | $10.48M 10-K · filed 2024-03-20 |
| 2021-02-28 | $8.38M derived: 10-K 9 month − 10-Q 6 month · filed 2024-03-20 | $9.10M derived: sum of 2 quarters · filed 2024-03-20 | $9.62M 10-K · filed 2024-03-20 | $10.43M derived: sum of 4 quarters · filed 2024-03-20 |
| 2020-11-29 | $725.00K derived: 10-Q 6 month − 10-K 3 month · filed 2022-01-07 | $1.24M 10-Q · filed 2022-01-07 | $2.05M derived: sum of 3 quarters · filed 2024-03-20 | $2.05M derived: sum of 4 quarters · filed 2024-03-20 |
| 2020-08-30 | $512.00K 10-K · filed 2024-03-20 | $1.32M derived: sum of 2 quarters · filed 2024-03-20 | $1.32M derived: sum of 3 quarters · filed 2024-03-20 | $2.09M derived: sum of 4 quarters · filed 2024-03-20 |
| 2020-05-31 | $810.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16 | $810.00K derived: sum of 2 quarters · filed 2023-03-16 | $1.58M derived: sum of 3 quarters · filed 2023-03-16 | $1.58M 10-K/A · filed 2023-03-16 |
| 2020-02-23 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-08 | $766.00K derived: sum of 2 quarters · filed 2021-04-08 | $766.00K 10-Q · filed 2021-04-08 | $766.00K derived: sum of 4 quarters · filed 2021-07-29 |
| 2019-11-24 | $766.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-07 | $766.00K 10-Q · filed 2021-01-07 | $766.00K derived: sum of 3 quarters · filed 2021-07-29 | $1.27M derived: sum of 4 quarters · filed 2021-07-29 |
| 2019-08-25 | $0.00 10-Q · filed 2020-10-07 | $0.00 derived: sum of 2 quarters · filed 2021-07-29 | $509.00K derived: sum of 3 quarters · filed 2021-07-29 | |
| 2019-05-26 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29 | $509.00K derived: sum of 2 quarters · filed 2021-07-29 | $509.00K 10-K · filed 2021-07-29 | |
| 2019-02-24 | $509.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | $509.00K 10-Q · filed 2020-04-03 | ||
| 2018-11-25 | $0.00 10-Q · filed 2020-01-02 | |||
| 2018-05-27 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | $0.00 10-K · filed 2020-08-14 | ||
| 2018-02-25 | $0.00 10-Q · filed 2019-04-04 | |||
| 2017-05-28 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01 | $0.00 derived: sum of 2 quarters · filed 2019-08-01 | $897.00K 10-K · filed 2019-08-01 | |
| 2017-02-26 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-05 | $902.00K 10-Q · filed 2018-04-05 | ||
| 2016-11-27 | $897.00K 10-Q · filed 2018-01-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |